Radiance Therapeutics is Therapeutic Devices in United States that focus on down-regulates fibroblasts business. Founded in 2018. They cover business area such as developer, glaucoma drainage surgery, scar tissue, reduce intraocular pressure, glaucoma surgery outcome, user, access, clinically demonstrate novel anti-metabolite therapy.
2018
( 6 years old in 2024 )
Down-regulates Fibroblasts
-
7440 North Oracle Road
Building 1
Tucson, AZ 85704
United States
Private
developerglaucoma drainage surgeryscar tissuereduce intraocular pressureglaucoma surgery outcomeuseraccessclinically demonstrate novel anti-metabolite therapy
* We use standard office opening hours in near Radiance Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Radiance Therapeutics is Therapeutic Devices business from United States that founded in 2018 (6 years old in 2024), Radiance Therapeutics business is focusing on Down-regulates Fibroblasts.
Radiance Therapeutics headquarter office and corporate office address is located in 7440 North Oracle Road Building 1 Tucson, AZ 85704 United States.
Radiance Therapeutics was founded in United States.
In 2024, Radiance Therapeutics is currently focus on down-regulates fibroblasts sector.
Above is snippet of Google Trends for "down-regulates fibroblasts" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Radiance Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
